0001062993-23-014996.txt : 20230718 0001062993-23-014996.hdr.sgml : 20230718 20230718163253 ACCESSION NUMBER: 0001062993-23-014996 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230714 FILED AS OF DATE: 20230718 DATE AS OF CHANGE: 20230718 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: D'Andrea Carrie CENTRAL INDEX KEY: 0001977969 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35776 FILM NUMBER: 231094667 MAIL ADDRESS: STREET 1: 3009, BOUL. DE LA CONCORDE EAST STREET 2: SUITE 102 CITY: LAVAL STATE: A8 ZIP: H7E 2B5 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acasti Pharma Inc. CENTRAL INDEX KEY: 0001444192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 3009, BOUL. DE LA CONCORDE EAST STREET 2: SUITE 102 CITY: LAVAL STATE: A8 ZIP: H7E 2B5 BUSINESS PHONE: 450-686-4555 MAIL ADDRESS: STREET 1: 3009, BOUL. DE LA CONCORDE EAST STREET 2: SUITE 102 CITY: LAVAL STATE: A8 ZIP: H7E 2B5 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-07-14 0001444192 Acasti Pharma Inc. ACST 0001977969 D'Andrea Carrie C/O ACASTI PHARMA INC. 3009 BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 QUEBEC, CANADA 0 1 0 0 VP Clinical Operations 0 Stock Options (Right to Buy) 2.64 2023-07-14 4 A 0 42000 0 A 2033-07-14 Class A Common Shares 42000 42000 D Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months. /s/ Prashant Kohli, as attorney-in-fact 2023-07-18